News

AI model algorithm tablet digital patient data

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

artificial intelligence AI predictive analytics

“The creation of an associate dean in AI speaks to the fact that AI has become central to research, education and clinical operations in the health care system."

Statue of Liberty New York City healthcare

In a complaint filed in federal court, the U.S. Department of Justice claims NewYork-Presbyterian Hospital uses its power of “scale, breadth and configuration” to control payer contracts, making it difficult for insurers to develop low-cost plans. The health system denies any wrongdoing.

Medical malpractice gavel diagnostic error mistake stethoscope

The disturbing case highlights a series of process errors and cost-cutting measures that ultimately led to the “never event” accident. 

Divaka Perera, MD, at ACC.26

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

voice audio recording smartphone

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

Thumbnail

Decreased screening rates among different subgroups highlight the ongoing need for outreach strategies that target vulnerable populations, experts contend.

artificial intelligence AI life sciences biopharma

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

The new 7,000-square-meter plant is located in France and will begin production of thorium-228, necessary for the development of isotopes used in cancer treatments. 

Left atrial appendage occlusion (LAAO) with the Watchman FLX device from Boston Scientific is associated with positive outcomes and limited adverse events after one year, according to new findings published in Circulation: Cardiovascular Interventions.[1] Many prior Watchman FLX studies, including PINNACLE FLX, had focused on the device’s performance in a controlled setting. The study’s authors hoped to gain a better understanding of its real-world impact by reviewing registry data from more than 97,000 U.S

The new data, presented during AHA Scientific Sessions 2024, suggest LAAC with Boston Scientific's Watchman FLX could be a safe, effective alternative to OAC for limiting post-ablation strokes.

doctor examines patient data on their tablet

Providing radiologists with key details about the patient's symptoms can go a long way toward improving the quality of their work. 

Around the web

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.